Koyama S - Search Results

1

Innate immune control of nucleic acid-based vaccine immunogenicity.

Koyama S, Coban C, Aoshi T, Horii T, Akira S, Ishii KJ. Koyama S, et al. Expert Rev Vaccines. 2009 Aug;8(8):1099-107. doi: 10.1586/erv.09.57. Expert Rev Vaccines. 2009. PMID: 19627190 Review.

2

Differential role of TLR- and RLR-signaling in the immune responses to influenza A virus infection and vaccination.

Koyama S, Ishii KJ, Kumar H, Tanimoto T, Coban C, Uematsu S, Kawai T, Akira S. Koyama S, et al. J Immunol. 2007 Oct 1;179(7):4711-20. doi: 10.4049/jimmunol.179.7.4711. J Immunol. 2007. PMID: 17878370

3

Cutting edge: cooperation of IPS-1- and TRIF-dependent pathways in poly IC-enhanced antibody production and cytotoxic T cell responses.

Kumar H, Koyama S, Ishii KJ, Kawai T, Akira S. Kumar H, et al. Among authors: koyama s. J Immunol. 2008 Jan 15;180(2):683-7. doi: 10.4049/jimmunol.180.2.683. J Immunol. 2008. PMID: 18178804

4

TANK-binding kinase-1 delineates innate and adaptive immune responses to DNA vaccines.

Ishii KJ, Kawagoe T, Koyama S, Matsui K, Kumar H, Kawai T, Uematsu S, Takeuchi O, Takeshita F, Coban C, Akira S. Ishii KJ, et al. Among authors: koyama s. Nature. 2008 Feb 7;451(7179):725-9. doi: 10.1038/nature06537. Nature. 2008. PMID: 18256672

5

Molecular and cellular mechanisms of DNA vaccines.

Coban C, Koyama S, Takeshita F, Akira S, Ishii KJ. Coban C, et al. Among authors: koyama s. Hum Vaccin. 2008 Nov-Dec;4(6):453-6. doi: 10.4161/hv.4.6.6200. Epub 2008 Nov 28. Hum Vaccin. 2008. PMID: 18535407 Review.

6

Host innate immune receptors and beyond: making sense of microbial infections.

Ishii KJ, Koyama S, Nakagawa A, Coban C, Akira S. Ishii KJ, et al. Among authors: koyama s. Cell Host Microbe. 2008 Jun 12;3(6):352-63. doi: 10.1016/j.chom.2008.05.003. Cell Host Microbe. 2008. PMID: 18541212 Free article. Review.

7

Innate immune response to viral infection.

Koyama S, Ishii KJ, Coban C, Akira S. Koyama S, et al. Cytokine. 2008 Sep;43(3):336-41. doi: 10.1016/j.cyto.2008.07.009. Epub 2008 Aug 9. Cytokine. 2008. PMID: 18694646 Review.

8

A signaling polypeptide derived from an innate immune adaptor molecule can be harnessed as a new class of vaccine adjuvant.

Kobiyama K, Takeshita F, Ishii KJ, Koyama S, Aoshi T, Akira S, Sakaue-Sawano A, Miyawaki A, Yamanaka Y, Hirano H, Suzuki K, Okuda K. Kobiyama K, et al. Among authors: koyama s. J Immunol. 2009 Feb 1;182(3):1593-601. doi: 10.4049/jimmunol.182.3.1593. J Immunol. 2009. PMID: 19155508

9

Cutting Edge: TLR-Dependent viral recognition along with type I IFN positive feedback signaling masks the requirement of viral replication for IFN-{alpha} production in plasmacytoid dendritic cells.

Kumagai Y, Kumar H, Koyama S, Kawai T, Takeuchi O, Akira S. Kumagai Y, et al. Among authors: koyama s. J Immunol. 2009 Apr 1;182(7):3960-4. doi: 10.4049/jimmunol.0804315. J Immunol. 2009. PMID: 19299691

10

Intranasal immunization with a mixture of PspA and a Toll-like receptor agonist induces specific antibodies and enhances bacterial clearance in the airways of mice.

Oma K, Zhao J, Ezoe H, Akeda Y, Koyama S, Ishii KJ, Kataoka K, Oishi K. Oma K, et al. Among authors: koyama s. Vaccine. 2009 May 21;27(24):3181-8. doi: 10.1016/j.vaccine.2009.03.055. Epub 2009 Apr 8. Vaccine. 2009. PMID: 19446189

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,906 results

Search Page